The predictive value of laboratory parameters in diagnosing gastrointestinal malignancy in older adults
Öz
Purpose: This retrospective study aimed to evaluate the predictive value of pre-endoscopic biochemical parameters for detecting malignant lesions in older adults undergoing upper and lower gastrointestinal (GI) endoscopies. Materials and Methods: We retrospectively analyzed 419 individuals aged 60 and above. Of these, 109 older adult patients who underwent both upper and lower GI endoscopies were included in the study. Patients with a prior history of GI cancer or those who could not complete the procedure due to intolerance were excluded. Patients were categorized based on the presence of benign or malignant lesions. Results: Malignant lesions were identified in 10.1% of patients (11/109). Statistically significant differences were observed between the benign and malignant groups in terms of hemoglobin (Hb), neutrophil count, mean corpuscular volume (MCV), neutrophil-lymphocyte ratio (NLR), iron (Fe), 25-hydroxyvitamin D [25(OH)D], C-reactive protein (CRP), total protein, albumin (Alb), blood urea nitrogen (BUN), CRP/albumin ratio (CAR), and aspartate aminotransferase (AST). The ROC curve analysis suggests that MCV, NLR, 25(OH)D, Fe, and CAR are valuable indicators for predicting malignant lesions in older adults, with optimal cut-off values of 79.5 fL, 3.28, 12 µg/L, 22 µg/dL, and 5.93, respectively. Conclusion: Laboratory parameters such as MCV, NLR, 25(OH)D, Fe, and CAR can support risk stratification when interpreted alongside clinical assessment and guideline-based recommendations.
Anahtar Kelimeler
Gastrointestinal Malignancy, Gastrointestinal endoscopy, Predictive, Older adult, Laboratory parameters
Destekleyen Kurum
Etik Beyan
Kaynakça
- Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229-63.
- Ministry of Health of the Republic of Türkiye, General Directorate of Public Health, Department of Cancer. Turkey cancer statistics 2020. Ankara: Ministry of Health of the Republic of Türkiye; 2020.
- Singh A. Global burden of five major types of gastrointestinal cancer. Prz Gastroenterol. 2024;19:236-54.
- Peterse EFP, Meester RGS, Siegel RL, Chen JC, Dwyer A, Ahnen DJ et al. The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis to inform the American Cancer Society colorectal cancer screening guideline. Cancer. 2018;124:2964-73.
- Kim GH, Bang SJ, Ende AR, Hwang JH. Is screening and surveillance for early detection of gastric cancer needed in Korean Americans? Korean J Intern Med. 2015;30:747-58.
- Hamashima C, Systematic Review Group, Guideline Development Group for Gastric Cancer Screening. Update version of the Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol. 2018;48:673-83.
- Moses PL, Smith RE. Endoscopic evaluation of iron deficiency anemia: A guide to diagnostic strategy in older patients. Postgrad Med. 1995;98:213-6.
- Rockey DC, Altayar O, Falck-Ytter Y, Kalmaz D. AGA technical review on gastrointestinal evaluation of iron deficiency anemia. Gastroenterology. 2020;159:1097-119.
- Midik MM, Gunenc D, Acar PF, Karaca BS. Prognostic value of blood-based inflammatory markers in cancer patients receiving immune checkpoint inhibitors. Cancers (Basel). 2024;17.
- Wautier JL, Wautier MP. Old and new blood markers in human colorectal cancer. Int J Mol Sci. 2022;23.
